• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Recognizing and preventing complications regarding bioresorbable scaffolds during coronary interventions.认识并预防冠状动脉介入治疗期间生物可吸收支架相关并发症。
World J Cardiol. 2024 Sep 26;16(9):508-511. doi: 10.4330/wjc.v16.i9.508.
2
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.依维莫司洗脱生物可吸收血管支架与依维莫司洗脱金属支架的比较:随机对照试验的荟萃分析。
Lancet. 2016 Feb 6;387(10018):537-544. doi: 10.1016/S0140-6736(15)00979-4. Epub 2015 Nov 17.
3
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.生物可吸收依维莫司洗脱支架与金属依维莫司洗脱支架治疗初发原生冠状动脉病变所致缺血性心脏病的比较(ABSORB II):一项随机对照临床试验的临床和操作次要终点 1 年中期分析。
Lancet. 2015 Jan 3;385(9962):43-54. doi: 10.1016/S0140-6736(14)61455-0. Epub 2014 Sep 14.
4
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.对比依维莫司洗脱生物可吸收支架与依维莫司洗脱金属支架治疗冠状动脉狭窄的疗效(ABSORB II):3 年随机、对照、单盲、多中心临床试验。
Lancet. 2016 Nov 19;388(10059):2479-2491. doi: 10.1016/S0140-6736(16)32050-5. Epub 2016 Oct 30.
5
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial.在 ABSORB II 试验中,生物可吸收依维莫司洗脱支架和金属依维莫司洗脱支架的术后对称性、扩张和偏心对临床结果的影响。
JACC Cardiovasc Interv. 2016 Jun 27;9(12):1231-1242. doi: 10.1016/j.jcin.2016.03.027. Epub 2016 Jun 1.
6
Coronary artery stent dislodgement and aortic dissection in a patient with a severely calcified lesion in the proximal right coronary artery.一名右冠状动脉近端存在严重钙化病变的患者发生冠状动脉支架移位及主动脉夹层。
J Cardiol Cases. 2017 Jul 27;16(4):105-108. doi: 10.1016/j.jccase.2017.05.004. eCollection 2017 Oct.
7
Personal Experience with Bioresorbable Scaffolds in Bifurcations.分叉病变中生物可吸收支架的个人经验
Interv Cardiol. 2013 Aug;8(2):93-95. doi: 10.15420/icr.2013.8.2.93.
8
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).植入可吸收依维莫司洗脱完全生物可吸收血管支架后急性支架断裂和晚期结构不连续性的发生率和影像学结果:ABSORB 队列 B 试验的光学相干断层成像评估(生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变患者的临床评价)。
JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016.
9
Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ABSORB III Trial.经皮冠状动脉介入治疗患者中生物可吸收血管支架与依维莫司洗脱支架的经济学结局:ABSORB III 试验 1 年结果。
JACC Cardiovasc Interv. 2017 Apr 24;10(8):774-782. doi: 10.1016/j.jcin.2017.01.022.
10
Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions.ABSBORB 生物可吸收血管支架与依维莫司洗脱支架治疗冠状动脉分叉病变的中期临床结果。
Int J Cardiol. 2017 Nov 1;246:26-31. doi: 10.1016/j.ijcard.2017.03.123.

本文引用的文献

1
Unloading and successful treatment with bioresorbable stents during percutaneous coronary intervention: A case report.经皮冠状动脉介入治疗期间使用生物可吸收支架进行卸载及成功治疗:一例病例报告。
World J Cardiol. 2024 Aug 26;16(8):484-490. doi: 10.4330/wjc.v16.i8.484.
2
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial.血管内超声指导与血管造影指导的急性冠状动脉综合征经皮冠状动脉介入治疗(IVUS-ACS):一项两阶段、多中心、随机试验。
Lancet. 2024 May 11;403(10439):1855-1865. doi: 10.1016/S0140-6736(24)00282-4. Epub 2024 Apr 8.
3
OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions.OCT 或血管造影指导复杂分叉病变的 PCI
N Engl J Med. 2023 Oct 19;389(16):1477-1487. doi: 10.1056/NEJMoa2307770. Epub 2023 Aug 27.
4
Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided Percutaneous Coronary Intervention: The OCTIVUS Randomized Clinical Trial.光学相干断层成像引导或血管内超声引导经皮冠状动脉介入治疗:OCTIVUS 随机临床试验。
Circulation. 2023 Oct 17;148(16):1195-1206. doi: 10.1161/CIRCULATIONAHA.123.066429. Epub 2023 Aug 27.
5
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study.用于治疗初次冠状动脉病变的新型可吸收镁支架(DREAMS 3):BIOMAG-I 首次人体研究的一年结果。
EuroIntervention. 2023 Aug 7;19(5):e414-e422. doi: 10.4244/EIJ-D-23-00326.
6
All calcified nodules are made equal and require the same approach: pros and cons.所有钙化结节都被一视同仁,且需要相同的处理方法:利弊分析。
EuroIntervention. 2023 Jun 5;19(2):e110-e112. doi: 10.4244/EIJ-E-23-00002.
7
Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study.第三代药物洗脱可吸收冠状动脉镁支架系统治疗初发冠状动脉病变患者的安全性和性能:前瞻性、多中心BIOMAG-I人体首次研究的6个月结果
EClinicalMedicine. 2023 Apr 17;59:101940. doi: 10.1016/j.eclinm.2023.101940. eCollection 2023 May.
8
First-in-human evaluation of a novel ultrathin sirolimus-eluting iron bioresorbable scaffold: 3-year outcomes of the IBS-FIM trial.首例人体新型超亲脂性雷帕霉素洗脱铁基可吸收支架的评估:IBS-FIM 试验 3 年结果。
EuroIntervention. 2023 Jun 19;19(3):222-231. doi: 10.4244/EIJ-D-22-00919.
9
Dislodged Coronary Stents: The Presnaring Technique.脱位的冠状动脉支架:预扩技术。
J Invasive Cardiol. 2023 Mar;35(3):E156-E157. doi: 10.25270/jic/22.00216.
10
Intravascular Imaging-Guided or Angiography-Guided Complex PCI.血管内影像学指导或血管造影指导下的复杂 PCI。
N Engl J Med. 2023 May 4;388(18):1668-1679. doi: 10.1056/NEJMoa2216607. Epub 2023 Mar 5.

认识并预防冠状动脉介入治疗期间生物可吸收支架相关并发症。

Recognizing and preventing complications regarding bioresorbable scaffolds during coronary interventions.

作者信息

Latsios George, Koliastasis Leonidas, Toutouzas Konstantinos, Tsioufis Kostas

机构信息

Department of Cardiology, Hippokration General Hospital, Athens Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.

出版信息

World J Cardiol. 2024 Sep 26;16(9):508-511. doi: 10.4330/wjc.v16.i9.508.

DOI:10.4330/wjc.v16.i9.508
PMID:39351339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11439101/
Abstract

The evolution of coronary intervention techniques and equipment has led to more sophisticated procedures for the treatment of highly complex lesions. However, as a result, the risk of complications has increased, which are mostly iatrogenic and often include equipment failure. Stent dislodgement warrants vigilance for the early diagnosis and a stepwise management approach is required to either expand or retrieve the lost stent. In the era of bioresorbable scaffolds that are not radiopaque, increased caution is required. Intravascular imaging may assist in detecting the lost scaffold in cases of no visibility fluoroscopically. Adequate lesion preparation is the key to minimizing the possibility of equipment loss; however, in the case that it occurs, commercially available and improvised devices and techniques may be applied.

摘要

冠状动脉介入技术和设备的发展催生了用于治疗高度复杂病变的更精密手术。然而,其结果是并发症风险增加,这些并发症大多是医源性的,且常常包括设备故障。支架移位需要警惕早期诊断,并且需要一种逐步的管理方法来扩张或取出丢失的支架。在不可显影的生物可吸收支架时代,需要更加谨慎。在荧光镜下不可见的情况下,血管内成像可能有助于检测丢失的支架。充分的病变预处理是将设备丢失可能性降至最低的关键;然而,如果发生设备丢失的情况,可以应用市售的和临时改进的设备及技术。